Volume 25, Number 3—March 2019
Research
Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017
Sarah Lepuschitz
, Werner Ruppitsch, Shiva Pekard-Amenitsch, Stephen J. Forsythe, Martin Cormican, Robert L. Mach, Denis Piérard, Franz Allerberger, and the EUCRONI Study Group
, Werner Ruppitsch, Shiva Pekard-Amenitsch, Stephen J. Forsythe, Martin Cormican, Robert L. Mach, Denis Piérard, Franz Allerberger, and the EUCRONI Study Group
Table 3
In silico evaluation of MLSTs for Cronobacter sakazakii strains in a multicenter study of C. sakazakii infections in humans, Europe, 2017*
| MLST | Total no. isolates | Human isolates detected in 2017 | Historical human isolates |
|---|---|---|---|
| 1 | 7 | 2 | 5 |
| 12 | 1 | 1 | – |
| 13 | 1 | 1 | – |
| 148 | 1 | – | 1 |
| 155 | 10 | – | 10 |
| 17 | 3 | 3 | – |
| 184 | 1 | 1 | – |
| 21 | 10 | 1 | 9 |
| 31 | 2 | 1 | 1 |
| 33 | 1 | 1 | – |
| 37 | 1 | 1 | – |
| 4 | 11 | 4 | 7 |
| 40 | 2 | 2 | – |
| 50 | 1 | – | 1 |
| 58 | 1 | 1 | – |
| 630 | 1 | 1 | – |
| 8 | 5 | 1 | 4 |
*MLST, multilocus sequence type; –, no isolates detected.
1Members of the EUCRONI study group are listed at the end of this article.
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.